BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

MASSPHOTON and Sino Innovation Lab Launch World’s First Medical-Grade UVC LED Air Sterilizer

The experience of the COVID-19 pandemic has heightened global awareness of air quality and indoor environmental safety like never before. MASSPHOTON a...

September 12, 2024 | News

HKBU’s Centre for Chinese Herbal Medicine Drug Development Receives Approval for Clinical Trial of Novel Ulcerative Colitis Drug

Centre for Chinese Herbal Medicine Drug Development (CDD) at Hong Kong Baptist University (HKBU) has achieved a significant milestone in dev...

September 05, 2024 | News

HKBU Research Identifies Phosphocholine as a Potential Therapy for PM2.5-Related Lung Damage

A research team led by Hong Kong Baptist University (HKBU) has discovered that phosphocholine, an important component in the body's metabolism, c...

August 28, 2024 | News

STADA Expands APAC Consumer Healthcare Portfolio with Acquisition of Nizoral Cream from Janssen

well as the trademark rights (TM) in Hong Kong, Australia, Indonesia, Malaysia, New Zealand and Singapore This transaction continues the successful acqu...

August 21, 2024 | News

STADA Expands APAC Consumer Healthcare Portfolio with Acquisition of Nizoral Cream from Janssen

well as the trademark rights (TM) in Hong Kong, Australia, Indonesia, Malaysia, New Zealand and Singapore This transaction continues the successful acqu...

August 20, 2024 | News

Akeso’s Ivonescimab Granted Priority Review by China's NMPA for First-Line Treatment of PD-L1 Positive NSCLC

Akeso, Inc. announced that the National Center for Drug Evaluation of the State Drug Administration of the People's Republic of China (NMPA CDE) ...

August 15, 2024 | News

AI Meets Life Sciences: How HKSTP and BioMap Are Transforming Hong Kong’s Biotech Landscape

In an exclusive interview with BioPharma APAC, Dr. Grace Lau, Head of Institute for Translational Research at Hong Kong Science and Technology Parks Corpor...

August 14, 2024 | Interview

Sirnaomics Forms Joint Venture with Gore Range Capital to Propel RNAi Therapeutics into Aesthetic Medicine

Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical co...

August 01, 2024 | News

PolyU Researchers Discover Key Mechanism in Eye Pressure Regulation for Glaucoma Treatment

Glaucoma is one of the leading causes of visual impairment and blindness. According to statistics from the Hospital Authority, in Hong Kong, three out of e...

July 26, 2024 | News

Sirnaomics Completes IND-Enabling Studies for siRNA Therapeutic STP125G Targeting ApoC3

Sirnaomics Ltd. (the “Company”, Stock Code: 2257.HK, together with its subsidiaries, the “Group” or “Sirnaomics”),...

July 24, 2024 | News

Pfizer Announces Launch of Bivalent RSV Vaccine in Hong Kong and Macau

Pfizer Inc. has announced the availability of its bivalent RSV prefusion F (RSVpreF) vaccine in Hong Kong this month. Approved by health authorities in Hon...

July 19, 2024 | News

CUHK Faculty of Medicine Identifies Gut Microbial Markers for Autism Diagnosis

The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) has conducted a large cohort study among 1,627 children with and w...

July 12, 2024 | News

Eisai and Biogen Announce Approval of LEQEMBI® (Lecanemab) for Alzheimer’s Disease Treatment in Hong Kong

LEQEMBI is now available for patients with mild cognitive impairment (MCI) or mild dementia, collectively referred to as early AD, the population in which ...

July 11, 2024 | News

Sirnaomics Completes Phase I Clinical Study of STP707 for Pancreatic Cancer with Strong Safety Profile and Promising Disease Stability

Sirnaomics , a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the Group h...

July 01, 2024 | News

Stay Connected